Inhibrx Biosciences, Inc.
INXBNASDAQHealthcare
$15.86
+$1.94(+13.94%)
Market Cap$225865416
P/E Ratio—
52W High$18.95
52W Low$12.95
Inhibrx Biosciences, Inc. (INXB) Stock Splits
No forward or reverse splits on record since IPO — details below.
FMP · INXB · as of May 30, 2024
Key split metrics
—
Inhibrx Biosciences, Inc. (INXB) has been publicly traded since Apr 24, 2018 with no forward or reverse splits on record.
About stock split history
Inhibrx Biosciences, Inc. (INXB) has never undergone a stock split since going public.
Frequently asked questions
Inhibrx Biosciences, Inc. (INXB) has never split its stock since going public.
INXB stock split historyhas INXB ever stock splitno stock split since IPO
Data: Financial Modeling Prep · Updated daily · For informational purposes only, not investment advice.